Standard Biotools (LAB) Change in Cash (2016 - 2026)
Standard Biotools has reported Change in Cash over the past 16 years, most recently at -$8.7 million for Q4 2025.
- Quarterly Change in Cash rose 79.8% to -$8.7 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$45.5 million through Dec 2025, down 139.14% year-over-year, with the annual reading at -$45.5 million for FY2025, 139.14% down from the prior year.
- Change in Cash was -$8.7 million for Q4 2025 at Standard Biotools, up from -$29.2 million in the prior quarter.
- Over five years, Change in Cash peaked at $235.8 million in Q1 2024 and troughed at -$62.6 million in Q3 2023.
- The 5-year median for Change in Cash is -$15.3 million (2025), against an average of -$95526.3.
- Year-over-year, Change in Cash plummeted 572.31% in 2021 and then skyrocketed 1997.52% in 2023.
- A 5-year view of Change in Cash shows it stood at -$39.2 million in 2021, then soared by 153.83% to $21.1 million in 2022, then tumbled by 232.41% to -$28.0 million in 2023, then plummeted by 54.27% to -$43.1 million in 2024, then soared by 79.8% to -$8.7 million in 2025.
- Per Business Quant, the three most recent readings for LAB's Change in Cash are -$8.7 million (Q4 2025), -$29.2 million (Q3 2025), and $7.7 million (Q2 2025).